Ukunyanga I-Acne Nge-Oral Minocycline

I-Minocycline yintsholongwane yomlomo eyenziwa ngokuqhelekileyo kwi-acne. Liyinto yeqela le-antibiotics ebizwa ngokuthi i- tetracycline (doxycycline kunye ne-tetracycline nayo ikwale qela, kwaye isetyenziselwa ukunyanga i-acne).

Kuzo zonke i-tetracycline, i-minocycline yona khetho ebiza kakhulu. Kodwa inokusebenza ngokuchasene ne-acne xa ezinye iintsholongwane zomlomo zingaphumeleli.

I-Minocycline isetyenziselwe amashumi eminyaka kwaye isebenza ngokuthe ngqo kwi-acne yokuvuvukala, nangona ingaqhelekanga isetyenziswe njengonyango lwe-solo. Iphantse ibhalwe njalo kunye kunye neyeza zonyango . Oku kuya kunika iziphumo ezingcono kunokusebenzisa kuphela i-minocycline yedwa.

I-Minocycline ibuye ithengiswe njengeMinocin, i-Dynacin, i-Vectrin, ne- Solodyn (ukukhululwa kwe-minocycline) .

Indlela i-Minocycline isebenza ngayo ukuphatha i-Acne

I-Minocycline isebenza ukuphatha i-acne ngeendlela ezimbini. Okokuqala, luyeka ukukhula kweebhaktheriya ezibangelwa ukuphuma kwe-acne . Okwesibini, i-minocycline inciphisa ukuvuvukala. Ukuba unombala obomvu, uphuthumele izibonda ezi ndaba ezilungileyo.

Ngakolunye uhlangothi, i-minocycline ayinakuyenza ininzi yamathambo kunye nezinye izibonda ezingekho . Ukhetho olungcono, kulo mzekelo, luya kuba yi -retinoids yama-topical .

Ezinye ii-Antibiotic zomlomo ezisetyenziselwa ukuphatha i-Acne

I-Minocycline ayiyona yodwa imithi yokulwa nomlomo esetyenziselwa ukuphatha i-acne. Ezinye iindlela zilandelayo:

Izikhokelo Zokusetyenziswa Ngokuqhelekileyo

Amashumi amahlanu ukuya kwi-100 mg, enye okanye kabini ngosuku, ngumlinganiselo oqhelekileyo wokuqala.

Nangona kucetyiswa ukuba kuthathwe kwisisu esingenalutho, i-minocycline ingathathwa kunye nokutya. Ngokungafani nezinye i-antibiotiki zomlomo, i-minocycline ifumene kakuhle, kwanokutya.

Ukungabi nako ukuthatha kwisisu esingenalutho kukudibanisa okukhulu, ngokukodwa kubafana abaselula abasoloko bebonakala belambile!

Uza kucima ngokukhawuleza unyango lwe-minocycline emva kokuba i-acne iphantsi kwelawulo. Ngeli nqanaba, i-acne iyakuthi igcinwe ingqwalaselo yonyango lwamayeza kuphela. Ngamanye amaxesha, nangona kunjalo, i-antibiotics yomlomo kufuneka ithathe ixesha elide ukugcina i-acne ekubuyeni.

Iimiphumo ezingasetyenziswayo zeMinocycline yomlomo

Iziphumo ezinokuthi zenzeke, nangona kuninzi kubantu abangekho kakhulu. Qinisekisa ukuba ukhangele kunye nodokotela wakho ukuba uyaphawula nayiphi na. Ezinye zeempembelelo eziqhelekileyo eziqhelekileyo:

Ukuqhaqhaqhaqhaqhaqha kweblue kunye nemilomo kuya kwenzeka nangokusebenzisa i-minocycline. Oku kuyazwakala kungaqhelekanga kwaye kuyothusayo, ewe, kodwa ngokuqhelekileyo kubakho kuphela ekusebenziseni ixesha elide kwaye kubuyeke kwakhona. Ukutshatyalaliswa kwezinyo (kwakhona, kwendalo ye-blue) kuya kwenzeka kwakhona. Kuyinto engavamile kakhulu, kodwa lo ungasigxina.

Kunqabile kakhulu, ukuthatha i-minocycline kunokubangela i-lupus eyenziwe ngamachiza. Kwakhona, oku kunqabile kwaye ngokuqhelekileyo kuhamba emva kokuyeka unyango.

I-Minocycline Ayilungile Wonke umntu

I-Minocycline ayifanele isetyenziswe xa ukhulelwe okanye uncelisa, ngoko ke ugqirha ugqirha ukuba uyazi ukuba kukho enye yale nto isebenza kuwe.

Kwakhona, abantwana abaneminyaka engaphantsi kweminyaka eyi-8 akufanele basebenzise i-minocycline, nangona ezinye iimithombo zincoma ukulinda de emva kweminyaka eyi-10 okanye eneminyaka engama-12. Thetha kwi-doc yakho ukufumana okulungileyo kwimeko yakho (okanye umntwana wakho).

Iingcebiso zokusebenzisa iMinocycline

> Imithombo:

> Leyden JJ, i-Del Rosso JQ "Ulwaphulo lomlomo lwe-antibiotic ye-acne vulgaris: i-pharmacokinetic ne-pharmacodynamic." J Clin Aesthet Deratol. 2011 Feb; 4 (2): 40-7.

> "I-Minocycline Oral" I-Medline Plus. AmaZiko eZiko lezeMpilo. 23 Agasti 11

> Mohammad S, Ruiz D. "I-Minocycline ye-acne vulgaris," i-Am Fam Physician. 2013 Septemba 1 88 (5): 300.

> Torok HM. "Ukwakhiwa kokukhululwa kwe-minocycline ekwenzeni unyango lwe-acne vulgaris ezinomlinganiselo osisigxina kwiminyaka engama-12." J Clin Aesthet Dermatol. 2013 Jul; 6 (7): 19-22.